MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants
Author(s) -
Vincenzo Summa,
Steven W. Ludmerer,
John A. McCauley,
Christine Fandozzi,
Christine Burlein,
Claudio Giuliano,
Paul J. Coleman,
Jillian DiMuzio,
Marco Ferrara,
Marcello Di Filippo,
Adam Gates,
Donald J. Graham,
Steven J. Harper,
Daria J. Hazuda,
Qian Huang,
Carolyn McHale,
Edith Monteagudo,
Vincenzo Pucci,
Michael Rowley,
Michael T. Rudd,
Aileen Soriano,
Mark W. Stahlhut,
Joseph P. Vacca,
David B. Olsen,
Nigel J. Liverton,
Steven S. Carroll
Publication year - 2014
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.03565-14
Subject(s) - genotype , ns3 , virology , protease inhibitor (pharmacology) , hepatitis c virus , biology , virus , microbiology and biotechnology , genetics , gene , viral load , antiretroviral therapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom